XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

The Company recorded employee and nonemployee share-based compensation expense as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

Employee

 

$

11,023

 

 

$

12,364

 

Nonemployee

 

 

1,581

 

 

 

1,676

 

 

$

12,604

 

 

$

14,040

 

Schedule of Stock-Based Compensation Expense

Share-based compensation expense is included in the following line items in the statements of operations (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

Research and development

 

$

2,560

 

 

$

4,355

 

General and administrative

 

 

10,044

 

 

 

9,685

 

 

$

12,604

 

 

$

14,040

 

 

Determining the appropriate fair value model to measure the fair value of the stock option grants on the date of grant and the related assumptions requires judgment. The fair value of each stock option grant is estimated using a Black-Scholes option-pricing model on the date of grant using the following inputs:

Schedule of Stock Options Valuation Assumptions Using a Black-Scholes Option Pricing Model

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

Estimated dividend yield

 

 

0.00

%

 

 

0.00

%

Weighted-average expected stock price volatility

 

 

87.93

%

 

 

87.15

%

Weighted-average risk-free interest rate

 

 

3.67

%

 

 

3.89

%

Expected term of options (in years)

 

 

5.63

 

 

 

5.78

 

Weighted-average fair value per option

 

$

10.58

 

 

$

17.41

 

Summary of Activity of Option Plans

The following table summarizes activity in the Company’s stock option plans for the years ended December 31, 2023 and December 31, 2024 :

 

 

 

Outstanding
Option
Shares

 

 

Weighted-
Average
Exercise Price

 

Balance as of December 31, 2022

 

 

457,097

 

 

 

191.07

 

Granted

 

 

20,443

 

 

 

23.61

 

Exercised

 

 

(3,196

)

 

 

9.59

 

Forfeited/canceled

 

 

(124,683

)

 

 

221.38

 

Balance as of December 31, 2023

 

 

349,662

 

 

 

172.13

 

Granted

 

 

85,034

 

 

 

10.58

 

Exercised

 

 

 

 

 

 

Forfeited/canceled

 

 

(58,145

)

 

 

166.04

 

Balance as of December 31, 2024

 

 

376,551

 

 

 

136.59

 

Summary of Restricted Stock Unit Activity

The following table summarizes the Company’s RSU activity for the years ended December 31, 2024 and December 31, 2023:

 

RSU Awards

 

Weighted-Average Grant Date Fair Value

 

Unvested RSUs as of December 31, 2022

 

120,550

 

 

 

106.49

 

Granted

 

161,161

 

 

 

34.49

 

Forfeited

 

(19,961

)

 

 

109.19

 

Vested

 

(46,893

)

 

 

112.02

 

Unvested RSUs as of December 31, 2023

 

214,857

 

 

51.03

 

Granted

 

 

881,233

 

 

 

10.33

 

Forfeited

 

 

(18,438

)

 

 

23.04

 

Vested

 

 

(102,132

)

 

 

55.51

 

Unvested RSUs as of December 31, 2024

 

 

975,520

 

 

 

14.32

 

Summary of Stock Options Granted under the Stock Option Plans are Vested or Expected to Vest

The following table summarizes certain information about stock options granted under the stock option plans which are vested or expected to vest as of December 31, 2024 and December 31, 2023.

 

Years Ended December 31,

 

 

 

Number of Options

 

 

Weighted-
Average
Remaining
Contractual
Life (in years)

 

 

Weighted-
Average
Exercise
Price

 

2024

 

Expected to be exercisable

 

 

376,551

 

 

 

7.10

 

 

$

136.59

 

2024

 

Currently exercisable

 

 

248,617

 

 

 

6.31

 

 

$

178.27

 

2023

 

Expected to be exercisable

 

 

349,662

 

 

 

7.15

 

 

$

172.13

 

2023

 

Currently exercisable

 

 

223,019

 

 

 

6.58

 

 

$

199.00

 

Summary of Stock Options Outstanding under the Stock Option Plans

The following table summarizes certain information about stock options outstanding under the stock option plans for the years ended December 31, 2024 and December 31, 2023, respectively:

 

Year Ended December 31, 2024

 

Exercise price

 

Number of Options Outstanding

 

 

Weighted- Average
Remaining Life

 

 

Number of Options Exercisable

 

$10.33 - $46.50

 

 

130,872

 

 

 

8.40

 

 

 

41,626

 

$50.40 - $100.20

 

 

77,207

 

 

 

7.35

 

 

 

61,168

 

$122.40 - $174.90

 

 

50,056

 

 

 

6.87

 

 

 

37,295

 

$189.30 - $293.70

 

 

60,916

 

 

 

6.20

 

 

 

53,729

 

$305.10 - $480.00

 

 

57,500

 

 

 

4.97

 

 

 

54,799

 

 

 

 

376,551

 

 

 

 

 

 

248,617

 

 

Year Ended December 31, 2023

 

Exercise price

 

Number of Options Outstanding

 

 

Weighted- Average
Remaining Life

 

 

Number of Options Exercisable

 

$12.30 - $46.50

 

 

67,401

 

 

 

7.65

 

 

 

27,084

 

$50.40 - $100.20

 

 

77,327

 

 

 

8.34

 

 

 

49,906

 

$122.40 - $174.90

 

 

64,477

 

 

 

7.35

 

 

 

35,163

 

$189.30 - $293.70

 

 

65,372

 

 

 

7.10

 

 

 

46,526

 

$305.10 - $480.00

 

 

75,085

 

 

 

5.33

 

 

 

64,340

 

 

 

 

349,662

 

 

 

 

 

 

223,019